Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients.

Montero, Paula; Pérez-Leal, Martín; Pérez-Fidalgo, Jose Alejandro; Sanz, Celia; Estornut, Cristina; Roger, Inés; Milara, Javier; Cervantes, Andrés; Cortijo, Julio

Montero, Paula; Pérez-Leal, Martín; Pérez-Fidalgo, Jose Alejandro; Sanz, Celia; Estornut, Cristina; Roger, Inés; Milara, Javier; Cervantes, Andrés; Cortijo, Julio.

Afiliação

Montero P; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Pérez-Leal M; Faculty of Health Sciences, Universidad Europea de Valencia, 46010 Valencia, Spain.
Pérez-Fidalgo JA; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
Sanz C; Biomedical Research Networking Centre on Cancer (CIBERONC), Health Institute Carlos III, 28029 Madrid, Spain.
Estornut C; INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Roger I; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Milara J; Health Sciences, Pre-Departmental Section of Medicine, Jaume I University of Castellón de la Plana, 12071 Castellón, Spain.
Cervantes A; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Cortijo J; Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.

Cancers (Basel) ; 14(5)2022 Feb 23.

Article em En | MEDLINE | ID: mdl-35267454

Palavras-chave

3D epidermis model; epidermis; paclitaxel; skin alterations

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google